Literature DB >> 31991290

Comparative whole corona fingerprinting and protein adsorption thermodynamics of PLGA and PCL nanoparticles in human serum.

Myolisi Ndumiso1, Nela Buchtová2, Lizex Husselmann3, Gadija Mohamed3, Ashwil Klein3, Marique Aucamp1, David Canevet4, Sarah D'Souza1, Retsepile E Maphasa1, Frank Boury2, Admire Dube5.   

Abstract

Nanoparticles (NPs) based on biocompatible and biodegradable polymers such as poly(lactic-co-glycolic acid) (PLGA) and polycaprolactone (PCL) represent effective systems for systemic drug delivery. Upon injection into the blood circuit, the NP surface is rapidly modified due to adsorption of proteins that form a 'protein corona' (PC). The PC plays an important role in cellular targeting, uptake and NP bio-distribution. Hence, the study of interactions between NPs and serum proteins appears as key for biomedical applications and safety of NPs. In the present work, we report on the comparative protein fluorescence quenching extent, thermodynamics of protein binding and identification of proteins in the soft and hard corona layers of PLGA and PCL NPs. NPs were prepared via a single emulsion-solvent evaporation technique and characterized with respect to size, zeta potential, surface morphology and hydrophobicity. Protein fluorescence quenching experiments were performed against human serum albumin. The thermodynamics of serum protein binding onto the NPs was studied using isothermal titration calorimetry. Semi-quantitative analysis of proteins in the PC layers was conducted using gel electrophoresis and mass spectrometry using human serum. Our results demonstrated the influence of particle hydrophobicity on the thermodynamics of protein binding. Human serum proteins bind to a greater extent and with greater affinity to PCL NPs than PLGA NPs. Several proteins were detected in the hard and soft corona of the NPs, representing their unique proteome fingerprints. Some proteins were unique to the PCL NPs. We anticipate that our findings will assist with rational design of polymeric NPs for effective drug delivery applications.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Human serum and nanoparticles; Nanoparticle protein corona; PLGA and PCL nanoparticles; Protein adsorption; Thermodynamics of protein binding

Mesh:

Substances:

Year:  2020        PMID: 31991290      PMCID: PMC7061085          DOI: 10.1016/j.colsurfb.2020.110816

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  42 in total

Review 1.  Single emulsion-solvent evaporation technique and modifications for the preparation of pharmaceutical polymeric nanoparticles.

Authors:  María G Nava-Arzaluz; Elizabeth Piñón-Segundo; Adriana Ganem-Rondero; David Lechuga-Ballesteros
Journal:  Recent Pat Drug Deliv Formul       Date:  2012-12

Review 2.  Biomolecule-nanoparticle interactions: Elucidation of the thermodynamics by isothermal titration calorimetry.

Authors:  Rixiang Huang; Boris L T Lau
Journal:  Biochim Biophys Acta       Date:  2016-02-03

Review 3.  Probing the interactions of proteins and nanoparticles.

Authors:  Jacob Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-06       Impact factor: 11.205

4.  Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles.

Authors:  Carl D Walkey; Jonathan B Olsen; Fayi Song; Rong Liu; Hongbo Guo; D Wesley H Olsen; Yoram Cohen; Andrew Emili; Warren C W Chan
Journal:  ACS Nano       Date:  2014-02-25       Impact factor: 15.881

Review 5.  Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date.

Authors:  Daniel Bobo; Kye J Robinson; Jiaul Islam; Kristofer J Thurecht; Simon R Corrie
Journal:  Pharm Res       Date:  2016-06-14       Impact factor: 4.200

6.  Beyond the protein corona - lipids matter for biological response of nanocarriers.

Authors:  Julius Müller; Domenik Prozeller; Artur Ghazaryan; Maria Kokkinopoulou; Volker Mailänder; Svenja Morsbach; Katharina Landfester
Journal:  Acta Biomater       Date:  2018-03-07       Impact factor: 8.947

7.  'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption.

Authors: 
Journal:  Colloids Surf B Biointerfaces       Date:  2000-10-01       Impact factor: 5.268

8.  Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.

Authors:  Hirenkumar K Makadia; Steven J Siegel
Journal:  Polymers (Basel)       Date:  2011-08-26       Impact factor: 4.329

9.  Multimodal nanoparticles that provide immunomodulation and intracellular drug delivery for infectious diseases.

Authors:  Admire Dube; Jessica L Reynolds; Wing-Cheung Law; Charles C Maponga; Paras N Prasad; Gene D Morse
Journal:  Nanomedicine       Date:  2013-12-10       Impact factor: 5.307

Review 10.  Control of polymeric nanoparticle size to improve therapeutic delivery.

Authors:  John W Hickey; Jose Luis Santos; John-Michael Williford; Hai-Quan Mao
Journal:  J Control Release       Date:  2015-10-09       Impact factor: 9.776

View more
  3 in total

1.  Rosmarinic Acid-Loaded Polymeric Nanoparticles Prepared by Low-Energy Nano-Emulsion Templating: Formulation, Biophysical Characterization, and In Vitro Studies.

Authors:  Jessica García-Melero; Joan-Josep López-Mitjavila; María José García-Celma; Carlos Rodriguez-Abreu; Santiago Grijalvo
Journal:  Materials (Basel)       Date:  2022-06-29       Impact factor: 3.748

Review 2.  Predicting the In Vivo Performance of Cardiovascular Biomaterials: Current Approaches In Vitro Evaluation of Blood-Biomaterial Interactions.

Authors:  Anne Strohbach; Raila Busch
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

Review 3.  Recent Advances in the Surface Functionalization of PLGA-Based Nanomedicines.

Authors:  Mazen M El-Hammadi; José L Arias
Journal:  Nanomaterials (Basel)       Date:  2022-01-22       Impact factor: 5.076

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.